SQI Diagnostics Inc News - SQD

L'OCRCVM permet la reprise de la négociation - SQD

L'OCRCVM permet la reprise de la négociation - SQD Canada NewsWire VANCOUVER, BC, le 10 janv. 2022 VANCOUVER, BC, le 10 janv. 2022 /CNW/...

IIROC Trading Resumption - SQD

IIROC Trading Resumption - SQD Canada NewsWire VANCOUVER, BC, Jan. 10, 2022 VANCOUVER, BC, Jan. 10, 2022 /CNW/ - Trading resumes in: Company:...

SQI ENTERS DEFINITIVE AGREEMENT TO ACQUIRE PRECISION BIOMONITORING'S HUMAN DIAGNOSTIC TESTING BUSINESS

SQI ENTERS DEFINITIVE AGREEMENT TO ACQUIRE PRECISION BIOMONITORING'S HUMAN DIAGNOSTIC TESTING BUSINESS Canada NewsWire TORONTO, Jan. 10, 2022...

Suspension de la négociation par l'OCRCVM - SQD

Suspension de la négociation par l'OCRCVM - SQD Canada NewsWire VANCOUVER, BC, le 10 janv. 2022 VANCOUVER, BC, le 10 janv. 2022 /CNW/...

IIROC Trading Halt - SQD

IIROC Trading Halt - SQD Canada NewsWire VANCOUVER, BC, Jan. 10, 2022 VANCOUVER, BC, Jan. 10, 2022 /CNW/ - The following issues have been halted...

SQI Diagnostics Inc. Closes Second and Final Tranche of Private Placement

SQI Diagnostics Inc. Closes Second and Final Tranche of Private Placement Canada NewsWire TORONTO, Nov. 8, 2021 /NOT FOR DISTRIBUTION TO U.S...

SQI Diagnostics Inc. Closes First Tranche of Private Placement with Insider Participation

SQI Diagnostics Inc. Closes First Tranche of Private Placement with Insider Participation Canada NewsWire TORONTO, Nov. 1, 2021 /NOT FOR...

SQI Diagnostics Inc. Responds to Change in FDA Priorities in Emergency Use Authorization

SQI Diagnostics Inc. Responds to Change in FDA Priorities in Emergency Use Authorization Canada...

SQI Diagnostics Inc. Announces Private Placement with Insider Participation

SQI Diagnostics Inc. Announces Private Placement with Insider Participation Canada NewsWire TORONTO, Sept. 24, 2021 /NOT FOR DISTRIBUTION TO U.S...

SQI Diagnostics Appoints Andrew Morris as Chief Executive Officer, and Grants Options

SQI Diagnostics Appoints Andrew Morris as Chief Executive Officer, and Grants Options Canada NewsWire TORONTO...

SQI Diagnostics Inc. Announces Grant of Stock Options

SQI Diagnostics Inc. Announces Grant of Stock Options Canada NewsWire TORONTO, Aug. 30, 2021 TORONTO, Aug...

SQI Diagnostics Reports Third Quarter 2021 Results

SQI Diagnostics Reports Third Quarter 2021 Results Canada NewsWire TORONTO, Aug. 18, 2021 TORONTO, Aug. 18...

FDA Stops Emergency Use Authorization Review of SQI Diagnostics RALI-Dx™ IL-6 Severity Triage Test for COVID-19 Patients

FDA Stops Emergency Use Authorization Review of SQI Diagnostics RALI-Dx™ IL-6 Severity Triage Test for...

SQI Diagnostics and AZOVA sign distribution agreement to sell SQI's COVID-19 HOME Antibody Test

SQI Diagnostics and AZOVA sign distribution agreement to sell SQI's COVID-19 HOME Antibody Test Canada...

SQI Diagnostics Inc. Announces $3.9 Million Funding via Warrant Exercise by Insiders

SQI Diagnostics Inc. Announces $3.9 Million Funding via Warrant Exercise by Insiders Canada NewsWire TORONTO...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

SQI Diagnostics Inc (SQD)

Professional-Grade Tools, for Individual Investors.

SQD News

L'OCRCVM permet la reprise de la négociation - SQD

IIROC Trading Resumption - SQD

SQI ENTERS DEFINITIVE AGREEMENT TO ACQUIRE PRECISION BIOMONITORING'S HUMAN DIAGNOSTIC TESTING BUSINESS

Suspension de la négociation par l'OCRCVM - SQD

IIROC Trading Halt - SQD

SQI Diagnostics Inc. Closes Second and Final Tranche of Private Placement

SQI Diagnostics Inc. Closes First Tranche of Private Placement with Insider Participation

SQI Diagnostics Inc. Responds to Change in FDA Priorities in Emergency Use Authorization

SQI Diagnostics Inc. Announces Private Placement with Insider Participation

SQI Diagnostics Appoints Andrew Morris as Chief Executive Officer, and Grants Options

SQI Diagnostics Inc. Announces Grant of Stock Options

SQI Diagnostics Reports Third Quarter 2021 Results

FDA Stops Emergency Use Authorization Review of SQI Diagnostics RALI-Dx™ IL-6 Severity Triage Test for COVID-19 Patients

SQI Diagnostics and AZOVA sign distribution agreement to sell SQI's COVID-19 HOME Antibody Test

SQI Diagnostics Inc. Announces $3.9 Million Funding via Warrant Exercise by Insiders

SQD Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

SQI Diagnostics Inc (SQD) News

SQI Diagnostics Inc (SQD)

Professional-Grade Tools, for Individual Investors.

SQD News

L'OCRCVM permet la reprise de la négociation - SQD

IIROC Trading Resumption - SQD

SQI ENTERS DEFINITIVE AGREEMENT TO ACQUIRE PRECISION BIOMONITORING'S HUMAN DIAGNOSTIC TESTING BUSINESS

Suspension de la négociation par l'OCRCVM - SQD

IIROC Trading Halt - SQD

SQI Diagnostics Inc. Closes Second and Final Tranche of Private Placement

SQI Diagnostics Inc. Closes First Tranche of Private Placement with Insider Participation

SQI Diagnostics Inc. Responds to Change in FDA Priorities in Emergency Use Authorization

SQI Diagnostics Inc. Announces Private Placement with Insider Participation

SQI Diagnostics Appoints Andrew Morris as Chief Executive Officer, and Grants Options

SQI Diagnostics Inc. Announces Grant of Stock Options

SQI Diagnostics Reports Third Quarter 2021 Results

FDA Stops Emergency Use Authorization Review of SQI Diagnostics RALI-Dx™ IL-6 Severity Triage Test for COVID-19 Patients

SQI Diagnostics and AZOVA sign distribution agreement to sell SQI's COVID-19 HOME Antibody Test

SQI Diagnostics Inc. Announces $3.9 Million Funding via Warrant Exercise by Insiders

SQD Discussion

Your Recent History